Combining relaxation exercises and aquatic therapy for fibromyalgia treatment
Combined Effects of Progressive Relaxation Exercises and Aquatic Therapy on Clinical Symptoms, Physical Function and Quality of Life in Patients With Fibromyalgia.
This study is testing whether combining relaxation exercises with aquatic therapy can help young women with fibromyalgia feel less pain and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 54 (estimated) |
| Ages | 20 Years to 39 Years |
| Sex | Female |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Rahim Yar Khan, Punjab Province) |
| Trial ID | NCT06460636 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the combined effects of progressive relaxation exercises and aquatic therapy on patients with fibromyalgia, a chronic pain condition. The study will involve a randomized controlled design with 54 participants, all of whom will be female and aged 20-39. Participants will be divided into two groups, receiving either the combined therapy or standard care, and their outcomes will be assessed using various scales to measure pain, quality of life, and other clinical symptoms. The trial aims to determine the efficacy of this novel therapeutic approach over an 8-week treatment period.
Who should consider this trial
Good fit: Ideal candidates for this study are married females aged 20-39 with a diagnosis of fibromyalgia meeting specific criteria.
Not a fit: Patients with severe cardiovascular issues, recent injuries or surgeries, or untreated psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and quality of life for women suffering from fibromyalgia.
How similar studies have performed: While there have been various interventions for fibromyalgia, the specific combination of progressive relaxation and aquatic therapy is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with age of 20-39 years will be included in this study 2. Married females 3. Only female patients will be included in this study. 4. Diagnosis of fibromyalgia according to established criteria of the American College of Rheumatology (I-e widespread pain index (WPI) ≥7 and symptom severity (SS) scale score ≥5 or WPI 3 - 6 and SS scale score ≥9. Symptoms present at least 3 months(2). 5. Patients having Pain in 11 of 18 tender points will be included. Exclusion Criteria: 1. Patients with Severe cardiovascular issues will be excluded. 2. Patients with recent injuries or surgeries within the last 6 months will be excluded. 3. Patients with untreated psychiatric disorders will be excluded.
Where this trial is running
Rahim Yar Khan, Punjab Province
- City Hospital, Rahim Yar Khan — Rahim Yar Khan, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Sabiha Arshad, M.phill — Riphah International University
- Study coordinator: Iqbal Tariq, PhD
- Email: iqbal.tariq@riphah.edu.pk
- Phone: 03458236752
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.